Latest Regulatory Change News

Page 1 of 28
Lifestyle Communities reported a transformative FY26 with a sharp rebound in new home sales, substantial debt reduction, and record homeowner satisfaction, despite ongoing market headwinds and regulatory uncertainty.
Eva Park
Eva Park
21 Aug 2026
SQX Resources launches a fully underwritten $2.47 million rights issue at a 31% discount to fund accelerated exploration across key US and Australian projects.
Maxwell Dee
Maxwell Dee
21 Aug 2026
QuickFee Limited swung to a A$39.3 million profit for FY26, propelled by the lucrative sale of its US Pay Now products, while trimming costs and declaring its first dividends.
Claire Turing
Claire Turing
21 Aug 2026
Ramelius Resources delivered 192,182 ounces of gold in FY26, meeting guidance for the sixth year, while integrating the Spartan acquisition and advancing key projects including the Rebecca-Roe DFS and Mt Magnet plant upgrade.
Maxwell Dee
Maxwell Dee
21 Aug 2026
APA Group (ASX:APA) posted an 81% jump in net profit after tax to AUD 234 million for FY26, driven by strong EBITDA growth, cost savings, and contributions from new assets. The company declared its 22nd consecutive distribution increase, advancing key infrastructure projects and sustainability goals.
Maxwell Dee
Maxwell Dee
20 Aug 2026
InvestSMART Group Limited swung to a net loss of $575,633 in FY26, marking a sharp reversal from the prior year’s profit, amid a strategic pivot including a pending $16 million sale of its Intelligent Investor business.
Claire Turing
Claire Turing
19 Aug 2026
WAM Global's FY2026 investment portfolio fell 4.2%, dragging the company to a $35.2 million net loss despite a 6.6 cent fully franked final dividend.
Claire Turing
Claire Turing
19 Aug 2026
Xenitra’s Hong Kong subsidiary Fukang has inked a three-year A$5 million procurement framework for specialised medical nutrition products, broadening its foothold beyond OTC medicines in China’s booming healthcare market.
Ada Torres
Ada Torres
18 Aug 2026
Amplitude Energy (ASX:AEL) posted record production and earnings for FY26, underpinned by strong operational execution and progress on the East Coast Supply Project (ECSP). The company strengthened its balance sheet, reduced net debt by 85%, and targets first gas from ECSP in 2028.
Maxwell Dee
Maxwell Dee
18 Aug 2026
Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.
Ada Torres
Ada Torres
17 Aug 2026
Scalare Partners offers 87 bonus options per 100 shares to eligible shareholders alongside piggyback options, aiming to mitigate dilution from upcoming convertible note conversions. Directors plan to exercise their options, with potential capital raised earmarked for working capital.
Claire Turing
Claire Turing
17 Aug 2026
The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.
Victor Sage
Victor Sage
17 Aug 2026

Browse the archive

Full archive